Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myeloma

Sandra Maria Dold; Veronika Riebl; Dagmar Wider; Marie Follo; Milena Pantic; Gabriele Ihorst; Justus Duyster; Robert Zeiser; Ralph Wäsch; Monika Engelhardt

doi:10.3324/haematol.2019.238394

Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myeloma

Haematologica. 2020 Oct 1;105(10):e523. doi: 10.3324/haematol.2019.238394.

Authors

Affiliations

¹ Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, Germany.
² Clinical Trials Unit, Medical Center - University of Freiburg, Faculty of Medicine, Germany.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Flow Cytometry
Humans
Multiple Myeloma* / diagnosis
Neoplasm, Residual
Transplantation, Autologous

Grants and funding

Funding: the work was supported through Deutsche Krebshilfe grants #109569 (to ME and RW) and #111424 (to ME and RW). which was funded by Gilead Sciences, Inc.